NewsDid Luxembourg Really Just Pay 3 Million Euros For...

Did Luxembourg Really Just Pay 3 Million Euros For 30 Kilos Of Medical Cannabis?

-

BEING the richest country in the world seems to have some inherent advantages. 

For Luxembourg has just spent €3m on 30 kilograms of medical cannabis – equating to the tidy sum of €100 per gram, reports Newsweed.

“The chosen offer is that of Canopy Growth Germany in collaboration with Tilray Germany. The products of the two suppliers come from Portugal and Canada,” said the Luxembourg Minister of Health Paulette Lenert in a written response addressed to a parliamentarian

Ms Lenert also specified that the Grand Duchy will receive 28.5 kilograms of cannabis flowers with a THC 18% / CBD ratio <1%, and 2.25 kilograms of herb balanced in THC / CBD.

This delivery is welcome in Luxembourg. The country has experienced a shortage of medical cannabis since March. The 700 or so patients treated with the flowers will soon be able to resume their treatment. This particularly concerns those who suffer from serious illnesses with chronic pain, cancer, or multiple sclerosis.

Equivalent To 100 Euros Per Gram

But this supply comes at a high price. 100 euros per gram is unheard of. “It must be a mistake, it’s not possible!, says Bertrand Rambaud, the representative of the Francophone Union for cannabinoids in medicine. 

Typically, wholesale purchase prices range from $2 to $3 per gram. Then on resale, it is around 7 euros. When I went to the Netherlands, the Bedrocan was sold at around €7.20 per gram. “

Luxembourgers also seem confused by this purchase price. In the commentary space of the newspaper L’Essentiel, many Internet users share their surprise: ‘100 euros per gram?! But it’s big nonsense’,’ Luxembourg is known to throw money down the drain’, ‘There must be an error, or then an intermediary who takes a good commission in the process’, were just some of the comments.

However, the government should not have too much trouble paying so much. Luxembourg is the richest country in the world, in terms of wealth per capita, according to the latest figures from the World Bank

But now, we will have to see how much Luxembourg medical cannabis will sell for. “If they buy it at 100 euros per gram, they will not sell it for 10 euros,” added Mr Rambaud.


1 COMMENT

  1. This is no help whatsoever to the people that actually need the medicine.

    Big companies still making huge amounts of profit, meanwhile people who are suffering cannot get hold of a natural medicine with no side effects that should be available to them cheaply and easily nearby. What a complete farce. This is very unfair on patients.

    I hope this is a mistake.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Plans Unveiled For First National Health Service-Backed Medical Cannabis Clinical Trial

AFTER launching a patient registry earlier this year further signs the UK’s National Health Service is warming to cannabis...

Reakiro – Europe’s Leading CBD And Hemp Brand – Delivers The Complete B2B & B2C Package

IN a time when CBD products are becoming unavoidable in the health, wellness and fitness industries, it is more...

Is Luxembourg’s Quest To Introduce An Adult-Use Cannabis Programme Going Up In Smoke?

CONCERNS over Luxembourg’s intent to become the first European country to legalise adult-use cannabis have emerged. In an interview on...

Cannabis Is Now A Compelling Opportunity For The Main Tobacco Companies

International cannabis expert, Barbara Pastori, of Prohibition Partners shares her thoughts on why cannabis is a compelling opportunity for...

Oxford Cannabinoid Technologies Holdings Sign Exclusive Worldwide License Agreement With Canopy Growth

Oxford Cannabinoid Technologies Holdings plc (OCTP), the holding company of Oxford Cannabinoid Technologies Ltd (“OCT”) (together, the “Group”), a...

With Global Cannabis Cultivation Capacity Set To Outstrip Demand One Hundredfold – What Happened To The ‘Green’ Rush?

CANNABIS investors need to be wary when it comes to cultivation, says Oliver Zugel, Founder and CEO FoliuMed Holdings. Where...

Must read

Plans Unveiled For First National Health Service-Backed Medical Cannabis Clinical Trial

AFTER launching a patient registry earlier this year further...

Is Luxembourg’s Quest To Introduce An Adult-Use Cannabis Programme Going Up In Smoke?

CONCERNS over Luxembourg’s intent to become the first European...

You might also likeRELATED
Recommended to you